This morning the top 3 gainers are in; now let’s do the reconciliation. The divergence after 8 hours is already quite clear.
NMR: stalled.
After the debut, the price fell 11.24%, while open interest decreased 9.61% to 9.1680 million. The funding rate dropped to -0.0991%, so the risk of a pullback from the highs still needs attention.
MARSCOIN: tug-of-war.
After the debut, the price dipped slightly by 0.57%, and open interest fell 2.17% to 30.0588 million. The aggressive buy/sell ratio moved from 0.87 to 0.98, and so far there’s no one-sided confirmation.
HBAR: tug-of-war.
After the debut, the price dropped 1.43%, and open interest decreased 3.18% to 59.6717 million. However, the aggressive buy/sell ratio rose from 0.96 to 1.15, and long/short positioning is still swinging back and forth.
In the evening, focus on whether open interest can stop declining and whether changes in the aggressive buy/sell ratio can turn into price confirmation.
When the gains narrow noticeably, especially watch out for high-level volatility amplifying.
#NMR #MARSCOIN #HBAR # contract replay
Claude Fable 5 assists in generating content; content is for market information only and does not constitute investment advice.
NMR: stalled.
After the debut, the price fell 11.24%, while open interest decreased 9.61% to 9.1680 million. The funding rate dropped to -0.0991%, so the risk of a pullback from the highs still needs attention.
MARSCOIN: tug-of-war.
After the debut, the price dipped slightly by 0.57%, and open interest fell 2.17% to 30.0588 million. The aggressive buy/sell ratio moved from 0.87 to 0.98, and so far there’s no one-sided confirmation.
HBAR: tug-of-war.
After the debut, the price dropped 1.43%, and open interest decreased 3.18% to 59.6717 million. However, the aggressive buy/sell ratio rose from 0.96 to 1.15, and long/short positioning is still swinging back and forth.
In the evening, focus on whether open interest can stop declining and whether changes in the aggressive buy/sell ratio can turn into price confirmation.
When the gains narrow noticeably, especially watch out for high-level volatility amplifying.
#NMR #MARSCOIN #HBAR # contract replay
Claude Fable 5 assists in generating content; content is for market information only and does not constitute investment advice.
